[{"type": "title", "data": "=Attributes!B2"}, {"type": "category", "data": "Admit/Transfer/Discharge"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "category", "data": "Medications"}, {"type": "sentence", "data": "None"}, {"type": "note", "data": "Exclusion Criteria:\n- CMV-seronegative recipient (R-)\n- Match related or unrelated allogeneic stem cell transplant with post-transplant cyclophosphamide", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "note", "data": "Inclusion Criteria:\n-CMV-seropositive recipient (R+) AND\n- High risk of CMV infection meeting ONE of the following criteria:\n- Umbilical cord blood transplant recipient\n- Haploidentical recipient\n- Recipient of ex-vivo T-cell depleted grafts\n- Recipient of mismatched related or mismatched unrelated allogeneic stem cell transplant\n- Recipient treated with with antithymocyte globulin (ATG) for conditioning\n- Recipient requiring high dose steroids (defined as 1 mg/kg/day or greater of prednisone, or wquivalent dose of another corticosteroid) for acute graft versus host disease (GVHD)\n- Recipient with documented history of CMV disease prior to transplantation\n- AND patient has undetectable CMV DNA at baseline (less than 35 IU/mL)\n-AND must be prescribed by a Leukemia/BMT or Transplant Infectious Disease provider", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "note", "data": "Select if patient is on cycloSPORINE. Start on Day +10 or up to Day + 28 and continue until Day + 100", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "order", "data": "letermovir", "value": ""}, {"type": "sentence", "data": "240 mg, PO, qdaily, Justification: No formulary alternative for indication, drug form:tab"}, {"type": "order", "data": "letermovir", "value": ""}, {"type": "sentence", "data": "240 mg, IV, qdaily,  Justification: No formulary alternative for indication, drug form:inj"}, {"type": "note", "data": "Select if patient is on TACrolimus. Start on Day +10 or up to Day + 28 and continue until Day + 100", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "order", "data": "letermovir", "value": ""}, {"type": "sentence", "data": "480 mg, PO, qdaily,  Justification: No formulary alternative for indication, drug form:tab"}, {"type": "order", "data": "letermovir", "value": ""}, {"type": "sentence", "data": "4800 mg, IV, qdaily,  Justification: No formulary alternative for indication, drug form:inj"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}]
